Common Sagebrush Solution
Product Images NDC 22840-2313

7 FDA label images from Greer Laboratories, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Common Sagebrush (NDC 22840-2313). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Greer Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2334 4 Iodinebush 10 Wv

2334 4 Iodinebush 10 Wv
Packaged label for Baccharis allergenic extract solution from Greer Laboratories, Inc., containing Iodinebush pollen (Allenrolfea occidentalis). The vial is 50 mL with a preservative of 0.4% phenol and potency of 50,000 PNU/mL. Label includes storage instructions (2-8°C), lot number 'SAMPLE', expiration date 01 Jan 2025, and U.S. Rx only information.*
FDA Label Image

5303 2 Green Amaranth 40 Wv

5303 2 Green Amaranth 40 Wv
The label of a sterile multiple dose vial features an allergenic extract of Green Amaranth Pollen (Amaranthus hybridus) in a 10 mL solution. It contains 0.2% phenol preservative and 50% v/v glycerin, with a concentration of 1:40 W/V. The product is manufactured by Greer Laboratories, Inc., and storage is recommended between 2 to 8°C. The label includes expiration date 01 Jan 2025 and unique identifiers such as GTIN, serial number, and lot number.*
FDA Label Image

Figure 1

Figure 1
Two-part illustration showing allergen extract dose measurement using a Greer Laboratories ruler. The left side displays two white plastic rulers with measurement scales and circles for allergen dose verification. The right side shows a close-up of the ruler used to measure a small liquid drop on skin, demonstrating dose accuracy for intradermal or percutaneous allergen testing.*
FDA Label Image

Figure 2

Figure 2
This image is a flowchart illustrating a skin testing algorithm related to allergenic exposure. It shows patient evaluation steps based on risk of systemic allergic reaction and results from percutaneous skin testing, guiding which concentration of test extract (various dilutions of weight/volume) to use. It also includes notes on positive and negative control applications.*
FDA Label Image

Length And Midpoint Orthogonal Width

Length And Midpoint Orthogonal Width
An instructional diagram showing an arm with a skin reaction from an intradermal test. The image highlights and labels a 'Wheal' as a smooth, slightly elevated area that is redder or paler than the surrounding skin, and a 'Flare (Erythema)' as the red outermost zone around the wheal. Accompanying text explains these terms.*
FDA Label Image

Measure The Flare

Measure The Flare
An instructional diagram showing an arm with a marked red spot indicating a test area. Two arrows measure the lesion's dimensions, noting a length of 36 mm and a width midpoint orthogonal of 26 mm. This likely depicts measurement of a skin reaction, relevant to allergenic testing procedures.*
FDA Label Image

Measuring The Wheal

Measuring The Wheal
An anatomical illustration of a forearm showing a circular red area labeled with measurements indicating a skin reaction size: length 16 mm and width midpoint orthogonal 10 mm. This likely depicts a skin test reaction area for Baccharis spp. allergenic solution testing.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.